Design and synthesis of novel pinacolylboronate containing combretastatin 'antimitotic agent' analogues

Tetrahedron Letters

Volumn 50, Issue 25, 2009, Pages 3031-3034

  Das, Bhaskar C ^a   Mahalingam, Sakkarapalayam M ^a   Evans, Todd ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Antimitotic agent; Combretastatin; Pinacolatoborane; Stilbene; TGF beta

Indexed keywords

ANTIMITOTIC AGENT; BORON DERIVATIVE; COMBRETASTATIN A4; PINACOLYLBORONATE; STILBENE DERIVATIVE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANTIMITOTIC ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; DRUG ACTIVITY; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; HORNER WADSWORTH EMMONS REACTION; MITOSIS INHIBITION; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION; WITTIG REACTION;

EID: 65449126167     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2009.04.003     Document Type: Article

References (35)

1. Liu F., Evans T., and Das B.C. Tetrahedron Lett. 49 (2008) 1578
2. Torregroza I., Evans T., and Das B.C. Chem. Biol. Drug Des. 73 (2009) 339
3. Hart J.H. Annu. Rev. Phytopathol. 19 (1981) 437
4. Farina A., Ferranti C., and Marra C. Nat. Prod. Res. 20 (2006) 247
5. The Merck index, 9th edn., Merk & Co., 1976, p. 414.
6. Dodds E.C., Goldberg L., Lawson W., and Robinson R. Nature 141 (1938) 247
7. Huggins C., and Hodges C.V. Cancer Res. 1 (1941) 293
8. Kirk, R. E.; Othmer, D. F., (Kirk-Othmer) Encyclopedia of Chemical Technology, 2nd ed.; Wiley-Interscience, 1969; vol. 19. p. 1, 13.
9. Oehlke A., Auer A.A., Jahre I., Walfort B., Rffer T., Zoufal P., Lang H., and Spange S. J. Org. Chem. 72 (2007) 4328
10. Tolomeo M., and Simoni D. Curr. Med. Chem: Anti-Cancer Agents 2 (2002) 387-401
11. Tron G.C., Pirali T., Sorba G., Pagliai F., Busacca S., and Genazzani A.A. J. Med. Chem. 49 (2006) 3033
12. Groziak M.P. In: Gribble G.C., and Gilchrist T.L. (Eds). Progress in Heterocyclic Chemistry Vol. 12 (2000), Pergamon, Oxford 1-21
13. Morin C. Tetrahedron 50 (1994) 12521-12569
14. Yang W., Gao X., and Wang B. Med. Res. Rev. 23 (2003) 346
15. Matteson D.S. Tetrahedron 45 (1989) 1859
16. Matteson D.S. Chem. Rev. 89 (1989) 1535
17. Tian Z.-Q., Brown B.B., Mack D.P., Hutton C.A., and Bartlett P.A. J. Org. Chem. 62 (1997) 514
18. Fevig J.M., Abelman M.M., Brittelli D.R., Kettner C.A., Knabb R.M., and Weber P.C. Bioorg. Med. Chem. Lett. 6 (1996) 295
19. Skordalakes E., Eligendy S., Goodwin C.A., Green D., Scully M.F., Kakkar V.V., Freyssinet J.-M., Dodson G., and Deadman J.J. Biochemistry 37 (1998) 14420
20. Leung D., Abbenante G., and Fairlie D.P. J. Med. Chem. 43 (2000) 305
21. Koehler K.A., and Lienhard G.E. Biochemistry 10 (1971) 2477
22. Thorpe P.E., Chaplin D.J., and Blakey D.C. Cancer Res. 63 (2003) 1144
23. Athar M., Ho Back J., Tang X., Ho Kim K., Kopelovich L., Bickers D.R., and Kim A.L. Toxicol. Appl. Pharmacol. 224 (2007) 274
24. Nicolas Di C., and Lakowicz J.R. J. Photochem. Photobiol A: Chem. 143 (2001) 39
25. Wittig:. Lautens M., and Mancuso J. J. Org. Chem. 69 (2004) 3478
26. Lautens M., and Marquardt T. J. Org. Chem. 69 (2004) 4607
27. Kobayashi Y., Tokoro Y., and Watatani K. Tetrahedron Lett. 39 (1998) 7537
28. Kobayashi Y., Tokoro Y., and Watatani K. Eur. J. Org. Chem. (2000) 3825
29. Horner-Wittig-Emmons:. Schmidt U., Leitenberger V., Griesser H., Schmidt J., and Meyer R. Synthesis (1992) 1248
30. Park K.C., Yoshino K., and Tomiyasu H. Synthesis (1999) 2041
31. Busnel O., Carreaux F., Carboni B., Pethe S., Goff S.V.-L., Mansuy D., and Boucher J.-L. Bioorg. Med. Chem. 13 (2005) 2373
32. Gopalarathnam A., and Nelson S.G. Org. Lett. 8 (2006) 7
33. Molander G.A., and Figueroa R. J. Org. Chem. 71 (2006) 6135
34. Zhang C., Zhemg G., Fang L., and Li Y. Synlett 3 (2006) 475
35. 4. The product was isolated by chromatography over silica gel.